The 1 analysts offering 12-month price forecasts for Infinity Pharmaceuticals Inc have a median target of 0.30, with a high estimate of 0.30 and a low estimate of 0.30. The median estimate represents a +9,900.00% increase from the last price of 0.00.
The current consensus among 1 polled investment analysts is to Hold stock in Infinity Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.11
Reporting Date May 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.